Skip to main content
. 2020 Jun 30;477(6):865–872. doi: 10.1007/s00428-020-02875-9

Table 3.

Variables (both original and alternative grading) and 5-year disease-specific survival in univariate calculations for the whole cohort, and for low-stage disease and high-stage disease separately. The percentage of patients surviving according to different grading is specified under DSS%

Whole cohort (n = 150) Low-stage (n = 78) High-stage (n = 63)
Variables All All All
DSS % p (n) DSS% p (n) DSS% p (n)
1.0 Differentiation, whole tumor 92.3/64.0/16.7 < 0.001 (127)* 94.7/84.6/40.0 0.002 (63)* 75.0/47.7/0 0.055 (55)
1.1 70.4/16.7 < 0.001* 87.7/40.0 0.001* 51.1/0 0.025 *
2.0 Differentiation, worst pattern 100/72.0/56.7 0.074 (124) 100/88.9/76.9 0.248 (63) 100/50.0/40.0 0.646 (54)
2.1 75.4/56.7 0.053 90.9/76.7 0.121 52.6/40.0 0.676
3.0 Keratinization whole tumor 85.0/68.0/53.6/47.6 0.038 (124)* 82.4/91.3/83.3/66.7 0.402 (61) 83.3/46.2/30.8/22.2 0.137 (54)
3.1 73.3/51.0 0.010 * 87.5/76.2 0.238 53.1/27.3 0.078
4.0 Keratinization, tumor front /100/70.3/59.7 0.047 (120)* ÷/100/89.5/75.8 0.133 (62) ÷/100/47.1/44.1 0.665 (52)
4.1 100/63.3 0.025* 100/80.8 0.146 100/45.1 0.374
5.0 Nuclear polymorphism 84.0/64.4/60.0/52.0 0.147(125) 100/85.7/84.6/50.0 0.004 (62)* 33.3/42.1/40.0/50.0 0.767 (54)
5.1 71.4/56.4 0.097 92.3/69.6 0.018* 40.0/44.8 0.673
6.0 Nuclear polymorphism, tumor front 66.7/75.0/68.8/57.5 0.507 (120) 100/94.7/64.2/64.7 0.054 (63) 20.0/46.7/40.0/54.5 0.363 (52)
6.1 72.9/62.5 0.302 96.2/75.0 0.029* 40.0/50.0 0.343
7.0 Perineural infiltration 70.0/52.9/28.6 0.003 (114)* 84.0/71.4/50.0 0.250 (59) 52.8/33.3/20.0 0.046 (50)*
7.1 70.0/45.8 0.020* 84.0/66.7 0.208 52.8/28.6 0.098
8.0 Lymphocytic infiltration 87.5/67.2/50.0 0.008 (123)* 100/87.5/56.3 0.003 (63)* 62.5/40.0/47.6 0.711 (54)
8.1 87.5/60.0 0.021* 100/77.1 0.050* 62.5/43.5 0.409
8.2 72.9/50.0 0.007* 91.5/56.3 0.001* 45.5/47.6 0.821
9.0 WPOI 100/70.6/82.8/58.9/56.3 0.190 (120) 100/80.0/100/77.8/66.7 0.224 (62) ÷/50.0/50.0/42.3/50.0 0.997 (52)
9.1 73.7/65.3 0.461 83.3/84.0 0.999 50,0/45.7 0.908
9.2 79.2/58.3 0.022* 93.1/75.8 0.061 50.0/44.4 0.902

*Significant at 0.05 level

HHS Vulnerability Disclosure